Platform & software · Radiation dose monitoring
Radiation dose monitoring software compared with dose tracking and radiation dose management systems
The short answer
Radiation dose monitoring software collects the radiation dose your imaging equipment reports, stores it against the patient and the protocol, and flags exams that fall outside your expected range. It is bought to satisfy three separate obligations: recording dose in the patient record, identifying dose outliers and benchmarking against peers, and producing the report your state or accrediting body asks for. The buying question most departments get wrong is regulatory status. A search of the FDA 510(k) database on September 15, 2026 returns zero clearances for Radimetrics, DoseWatch, DoseTrack, DoseMonitor, Imalogix and teamplay. That is not an oversight. This category sits under 21 CFR 880.6310, the Medical Device Data System rule, product code OUG, which is Class I, and Imalogix is registered there. So clearance cannot separate these vendors, and the things that actually can are which dose data sources the product reads, whether it handles your older scanners, and what it costs.
Dose monitoring gets bought on a demo and regretted at the first audit. The demo always looks the same: a dashboard of CTDIvol by protocol, a red row where somebody scanned a child on an adult setting, a quarterly comparison against a national median. Every product in this category can draw that screen.
What separates them is upstream of the dashboard, in whether the dose data arrives at all. Modern scanners emit a DICOM Radiation Dose Structured Report, which is a clean machine-readable record of what was delivered. Most CT scanners built since around 2012 produce one. Older units, and a good deal of fluoroscopy and interventional equipment, do not. They produce a dose screen as a secondary capture image, which is a picture of a number, and getting that into a database means optical character recognition and a tolerance for error. A department with a mixed fleet is buying an extraction problem, not a dashboard.
The second thing that separates them is the obligation you are actually trying to meet, because there are several and they do not overlap neatly. California has required since July 1, 2012 that the dose be recorded on every diagnostic CT study in the patient's record, and that the interpretive report either state the dose or have the protocol page attached to it. The Joint Commission requires CT dose documentation in the clinical record along with identification of dose incidents and external benchmarking. Medicare's XR-29 provision under PAMA is about the scanner's own capabilities rather than your software. The ACR Dose Index Registry is voluntary benchmarking you opt into. A product can serve one of these well and the others barely at all.
This page is a buyer's guide to that category. Radiological.ai is not a dose monitoring system and does not collect dose data. The one place the two genuinely touch is the California requirement that the dose appear in the interpretive report, because getting a number reliably into signed report text is a structured reporting problem, and that is the part we work on.
Worklist
Structured report
DraftRun the assistant to draft this report for review.
Decision support. The radiologist reviews and signs every study.
Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional judgment.
Flag · prioritize · draft · you review and sign
Decision support not a diagnosis
You review & sign
Dose data reaches a monitoring product through the same plumbing as everything else in a radiology department, so the integration questions are the ones covered in radiology PACS integration, DICOM and HL7. Which platform holds the images in the first place is a separate purchase, worked through in PACS software and PACS system vendors compared by study volume, and where they live long term in enterprise imaging and vendor neutral archive software. The operational half, where protocols and scheduling live, is the radiology information system.
The California rule lands on the report rather than on a dashboard, which makes it a documentation problem: see structured radiology reporting for how discrete fields get a number into signed text consistently, and the radiology reporting software comparison for the products that do it. For what surrounding radiology software costs against federal contract data, radiology software pricing breaks it down by category, and the contract terms worth negotiating covers renewal uplift and the fully loaded first-year total.
Side by side
Five radiation dose management products, compared on what actually differs
Every product here draws a dose dashboard. The columns below are the things that vary between them, and the FDA row is the one most procurement checklists get wrong.
| What you are comparing | Bayer Radimetrics | GE DoseWatch | Sectra DoseTrack | PACSHealth DoseMonitor | Imalogix |
|---|---|---|---|---|---|
| FDA 510(k) clearances for the dose product | None | None | None | None | None |
| How the category is regulated instead | Medical Device Data System territory, 21 CFR 880.6310, Class I | Same | Same | Same | Registered with FDA under product code OUG, Medical Device Data System, Class I |
| Parent company and what else it sells you | Bayer, which also sells the MEDRAD contrast injectors the dose data often references | GE HealthCare, so the scanners and the dose software come from one vendor | Sectra, whose PACS and enterprise imaging you may already run | PACSHealth, sold and supported in federal contracts through PHS Technologies Group | Independent, which is the argument for it if you want a vendor-neutral read on your own fleet |
| Federal prime contract awards found | 9 awards, $938,458 total | 5 awards, $491,538 total | None found | 8 awards, $435,358 total | None found |
| Median federal award | $93,262 | $91,000 | No data | $36,000 | No data |
| Most recent federal award seen | $212,601, VISN 8, October 2025 | $91,000 maintenance, October 2019 | No data | $74,064 service and support, September 2026 | No data |
| Who buys it in the public record | Mostly VA networks, through Bayer directly and through resellers | VA sites, contracted through GE | No federal record found | VA sites, through PHS Technologies Group, GlobalMax and Agfa | No federal record found |
| The honest case against it | You are buying dose analytics from the company that sells you contrast injectors | Single-vendor convenience cuts both ways if you later move off GE scanners | Strongest if you already run Sectra; less obvious if you do not | Smaller vendor, and the federal footprint runs through resellers rather than direct | No federal contract trail to check, so ask for reference sites of your own size |
FDA rows were checked against the openFDA 510(k) and registration and listing endpoints on September 15, 2026. Federal award figures are prime contract awards from USAspending.gov, retrieved September 15, 2026, with every recipient name and award description read individually before it was counted. A zero in the award row means no prime contract matched that product name in that database, not that the product is unavailable in the United States. Vendor ownership and feature scope change; confirm current products and pricing with any vendor before building a shortlist around this table.
Why it works
What your group gets with radiation dose monitoring
No product in this category has an FDA clearance
Searched on September 15, 2026, the openFDA 510(k) database returns zero clearances for Radimetrics, DoseWatch, DoseTrack, DoseMonitor, Imalogix and teamplay. The zero is real and it survives a cross-check: Bayer holds clearances, but for MEDRAD injectors rather than Radimetrics, and Sectra holds them for its pathology module, its workstation and its mammography system rather than for DoseTrack. The reason is that dose monitoring software moves and displays device data without altering how any device behaves, which is the definition of a Medical Device Data System at 21 CFR 880.6310, product code OUG, Class I. Imalogix appears in the FDA registration and listing database under exactly that code. If a procurement checklist scores these vendors on clearance, it will score all of them zero and learn nothing.
Real prices sit between about $25,000 and $250,000
Twenty-two federal prime contract awards for these products appear on USAspending, totaling $1,865,354, with a median of $70,500 and a range from $9,548 to $249,810. Radimetrics accounts for nine of them, including $249,810 through Change Healthcare in August 2019 and $212,601 for VISN 8 in October 2025. DoseWatch accounts for five, topped by $217,413 in February 2015 for a workstation and core license. DoseMonitor accounts for eight, including $137,401 to Agfa HealthCare in April 2026 and $74,064 in September 2026. These are federal prices for specific scopes rather than a list price, and many are maintenance renewals rather than new purchases, so read them as a sense of scale.
The California rule is about your report, not your dashboard
California Health and Safety Code section 115111 has required since July 1, 2012 that the dose of radiation be recorded on every diagnostic CT study in the patient record, and that the interpretive report either include the dose or have the protocol page attached. The dose is defined as CTDIvol and dose length product. A dashboard does not satisfy that. Text in the signed report does. Radiological.ai does not collect dose data and is not a dose monitoring system, but getting a required value reliably into signed report text is a structured reporting problem, and that is where it works: it drafts the structured report into your own template so required fields are present and consistent across readers. The radiologist reviews, edits and signs every study.
What it handles
Flagged, prioritized and drafted for your review
The assistant pre-reads each study, surfaces a region of interest for review, re-prioritizes the worklist, and drafts the structured report in your template. You confirm, edit and sign.
- Drafts the structured report into your own template so required fields land in signed text consistently
- Keeps documentation consistent across readers, which is what a dose disclosure requirement actually tests
- Surfaces suspected findings for a second look before the report is signed
- Prioritizes the worklist so urgent studies are read first
- Works alongside your existing RIS, PACS and dose monitoring system rather than replacing any of them
- Radiologist reviews, edits and signs every study
Region of interest flagged for review
A focal region is surfaced on the sample study for the radiologist to review. The assistant does not characterize it as a diagnosis.
Suspected finding flagged for radiologist review. Correlate clinically and confirm. Draft for review and sign-off.
Why Radiological.ai
One assistant across the whole read
Not three vendors stitched together. Flag, prioritize and draft in one calm pane, on X-ray, CT and MRI, with the radiologist signing every study.
Flags suspected findings
A second set of eyes surfaces regions of interest for review on every study, so a suspected finding is less likely to slip past late in a shift.
Prioritizes the worklist
Suspected-critical studies move to the top, so urgent reads surface ahead of routine follow-ups across your sites and shifts.
Drafts the report
A structured draft arrives in your template, ready to edit and sign. The draft saves the typing and the measuring, never the judgment.
Good questions
Questions about radiation dose monitoring
Explore more
More ways teams read with Radiological.ai
Radiology AI platform
One assistant across the whole read, not three point tools stitched together.
Learn moreAI medical imaging
A workflow assistant for the imaging your team reads every day.
Learn moreAI radiology assistant
An assistant that reads alongside you and drafts before you sit down.
Learn moreFrom the blog: best AI radiology software in 2026, how much radiology AI costs, how to implement AI in a radiology workflow, and AI radiology companies.
Read more studies, with the assistant alongside you
Flag suspected findings, prioritize the worklist, and draft the structured report. You review and sign every study.
Radiological.ai is a workflow and decision-support tool for qualified clinicians. It does not provide a diagnosis and is not a substitute for professional medical judgment.